Chapter

Carcinoid and Drug-Related Heart Disease

Heidi M. Connolly and Patricia A. Pellikka

in Mayo Clinic Cardiology

Fourth edition

Published on behalf of © Mayo Foundation for Medical Education and Research

Published in print November 2012 | ISBN: 9780199915712
Published online May 2013 | e-ISBN: 9780199322824 | DOI: http://dx.doi.org/10.1093/med/9780199915712.003.0820

Series: Mayo Clinic Scientific Press

Carcinoid and Drug-Related Heart Disease

Show Summary Details

Preview

Progress in the medical and surgical management of patients with metastatic carcinoid tumor has resulted in improved symptoms and survival. However, carcinoid heart disease remains a major cause of morbidity and death. Limited medical treatment options are available for patients with carcinoid valvular disease; for those with severe valvular heart disease, valve replacement has been increasingly used. Clinical and echocardiographic features and management are reviewed in this chapter. Drug-related heart disease, also covered in this chapter, has been linked to some anorexigens, ergot alkaloids, and pergolide.

Chapter.  3075 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.